Liabooks Home|PRISM News
PRISM

#biotechnology

Total 6 articles

Close-up of a vaccine vial in a high-tech lab
ViralEN
From Scabs to DNA: The Evolution and Science of Modern Vaccine Manufacturing

Explore the modern vaccine manufacturing science, from live attenuated viruses to the truth about ingredients like adjuvants and thimerosal.

AlphaFold at 5: Google DeepMind's 'AI Co-scientist' is Now Debating Hypotheses to Simulate a Human Cell
TechEN
AlphaFold at 5: Google DeepMind's 'AI Co-scientist' is Now Debating Hypotheses to Simulate a Human Cell

Five years after its debut, Google DeepMind's AlphaFold is evolving from a protein structure predictor into an 'AI co-scientist.' Built on Gemini 2.0, it's generating hypotheses and tackling the grand challenge of simulating a human cell.

The Great Scientific Migration: Why a Top Scientist's Return to China Signals a Geopolitical Power Shift
PoliticsEN
The Great Scientific Migration: Why a Top Scientist's Return to China Signals a Geopolitical Power Shift

A top US-trained scientist's return to China is not an isolated event. It's a critical signal of a reversing brain drain in the global tech and talent war.

China's Blood Heist: Why a Smuggling Bust Signals a New Front in the US-China Tech War
PoliticsEN
China's Blood Heist: Why a Smuggling Bust Signals a New Front in the US-China Tech War

A massive blood-smuggling bust in China is more than a crime story. It's a signal of Beijing's new biosecurity state and a new front in the US-China tech war.

US Defense Bill Sharpens Tech War: Why the NDAA is a New Frontline Against China
PoliticsEN
US Defense Bill Sharpens Tech War: Why the NDAA is a New Frontline Against China

The new US NDAA isn't just a defense bill; it's a strategic move to decouple key tech and biotech sectors from China. We analyze the global impact.

The End of Trial-and-Error: OpenAI's New Framework Puts Biology on Autopilot
TechEN
The End of Trial-and-Error: OpenAI's New Framework Puts Biology on Autopilot

OpenAI is using a GPT-5 model to automate biological research. Our analysis shows this signals the end of traditional R&D and the rise of the 'AI Scientist'.